PAD - Prescribing Advisory Database
Surrey
Prescribing Advisory Database

Guidelines : Osteoporosis

Detail

Condition :
Osteoporosis
Keywords :
bisphosphonates, postmenopausal osteoporosis, bone density, abaloparatide, romosozumab, teriparatide
BNF Codes :

Committee Recommendations

Date
Committee Name
Narrative
Traffic Light Status
06 November 2024

The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed an High Cost drug Osteoporosis pathway as a temporary measure until the entire Algorithm 1 is reviewed.

Abaloparatide has been added to the algorithm following the publication of NICE TA991.

Please note that algorithm 1 in the Osteoporosis Guidelines has not been updated

 
See narrative
03 August 2022

The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed an updated Osteoporosis Treatment Pathway - Algorithm 1.

Romosozumab has been added to the algorithm following the publication of NICE TA791 in May 2022. 

Please note that algorithm 1 in the Osteoporosis Guidelines has not been updated

 
N/A
02 June 2021

The Osteoporosis guidelines have been reviewed and updated.

The guidelines are supported by two algorithms which have been extracted from the guideline and provided as separate documents (below) for ease of use:
Algorithm 1 - Treatment Pathway for adults
Algorithm 2 - Review of Long-term Bisphosphonate Therapy 

Calcium & vitamin D:
AdcalD3/ AccreteD3 twice daily formulations are the preferred calcium and vitamin D supplements.
Accrete D3 One a Day, Calci-D chewable tablets or theiCal-D3 chewable tablets are once daily options for patients with compliance issues.
 

 
N/A

Documents

Supplementary documents (CCG specific documents)

No records returned.

Drugs

Below are listed drugs that are used to treat Osteoporosis.